Filing Details
- Accession Number:
- 0001127602-15-019730
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-03 16:55:13
- Reporting Period:
- 2015-06-01
- Filing Date:
- 2015-06-03
- Accepted Time:
- 2015-06-03 16:55:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
859737 | Hologic Inc | HOLX | X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844) | 042902449 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1265751 | Nancy Leaming | 35 Crosby Drive Bedford MA 01730 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-06-01 | 12,517 | $13.07 | 50,465 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2015-06-01 | 2,800 | $18.96 | 53,265 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-06-01 | 15,317 | $36.25 | 37,948 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2015-06-01 | 12,517 | $0.00 | 12,517 | $13.07 |
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2015-06-01 | 2,800 | $0.00 | 2,800 | $18.96 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2016-01-01 | No | 4 | M | Direct | |
0 | 2006-07-01 | 2016-01-01 | No | 4 | M | Direct |
Footnotes
- The transaction reported herein reflects an aggregate of sales at prices ranging from $36.15 and $36.35, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full disclosure with respect to the number of shares purchased at each separate price.
- This option becomes fully vested on January 1, 2014.